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Wednesday, February 24, 2010 719ashowed no structural defects compared to control littermates. Additionally, ex-
amination of these hearts by immunofluorescence microscopy revealed normal
myofibrillar structure and localization of the transgenic protein to intercalated
disks, as normally seen with the endogenous protein. Protein markers for car-
diomyopathy were examined by qPCR and revealed no difference between
non-transgenic and transgenic animals. Echocardiography and magnetic reso-
nance imaging of the N-RAP transgenic animals revealed no significant struc-
tural or functional differences when compared to control littermates at 12
weeks of age. Based on these data, it does not appear that overexpression of
N-RAP directly leads to an observable cardiac phenotype. The alternative hy-
pothesis that upregulation of N-RAP in dilated cardiomyopathy is compensa-
tory remains to explored.
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We sought to establish a model of heart failure (HF) encompassing young and
aged animals to determine if alterations in the amount of cardiac extracellular
matrix (ECM) occur in ageing and whether these changes are similar to those in
HF.
HF was induced in sheep aged 18 months (young) and those over 8 years (old)
by 4 weeks rapid right ventricular pacing (3.5Hz). Paraffin-embedded left ven-
tricular (LV) samples were stained with picro-sirius red. Interstitial collagen
was visualised by polarised light microscopy. LV protein extracts were as-
sessed for MMP activity using gelatin zymography. Statistical significance
was calculated using the mean 5 SEM and a t-test or by 2-way ANOVA.
LV diameter increased with age (OC) compared to young controls (YC)
(3.0450.2cm vs.2.4450.14cm, n=4-13, P<0.05), in young heart failure
(YF) compared pre-pacing (3.8250.1cm vs. 2.4450.1cm, n=13, P<0.001)
and in old heart failure (OF) compared to pre-pacing (3.8750.1cm vs.
3.0450.2cm, n=4, P<0.05). Collagen content increased in OC compared to
YC (2.2750.4% vs. 0.9650.1%, n=5, P<0.05) and in YF compared to YC
(2.6250.3% vs. 0.9650.1%, n=5-8, P<0.001), and decreased in OF compared
to YF (1.2650.4% vs. 2.6250.3%, n=4-8, P<0.01). Normalised MMP-2 ac-
tivity increased in OC (1.5250.08), YF (1.6650.14) and OF (1.7450.17)
compared to YC (0.9850.22, P<0.05, n=6-8).
The commonality of these changes seen in ageing and HFmay indicate that car-
diac ECM remodelling is important in the predisposition of ageing to the devel-
opment of HF.
All procedures accord to The UK Animals (Scientific Procedures) Act, 1986.
This work was supported by the British Heart Foundation and EU
‘‘Normacor’’.
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Previously we have characterized the physiological heart hypertrophy which
occurs during pregnancy. However, the underlying molecular mechanisms of
pregnancy-induced hypertrophy are still not elucidated. Here we performed
Western Blot analysis together with high resolution confocal microscopy to
identify the key signaling molecules involved in the pregnancy-induced heart
hypertrophy in non-pregnant in diestrus stage (NP), late pregnant (LP), 24
hours post partum (PP1) and 7 days post partum (PP7) mice. Western Blot anal-
ysis of heart lysates showed that phospho-AKT protein levels were decreased
~ 7 fold at the end of pregnancy (N=4NP and N=4 LPmice). Interestingly, AKT
activity was restored one day post-partum to levels comparable to NP. There
were no significant changes in total or phosphorylated levels of ERK1/2 with
pregnancy. The calcium/calmodulin-dependent serine-threonine phosphatase
Calcineurin, which has been shown to be upregulated in pathological cardiac
hypertrophy, was significantly downregulated at the end of pregnancy, and
this downregulation was reversed 1 day after partum. The phosphorylation of
the signal transducer and activator of transcription 3 (STAT3), but not its total
protein levels, was also significantly lower at the end of pregnancy and was re-
stored completely one day post-partum.Although therewas a tendency in reduc-
tion of phospho-GSK protein levels in the LP group, this reduction was not
statistically significant. High resolution confocal microscopy demonstrated
that pregnancy is associated with relocalization of AKT and pAKT to the nu-
cleus, which is partially reversed 24 hours post-partum. While the subcellulardistribution of ERK1 and pERK was not regulated by pregnancy, the nuclear
labeling of P38, JNK1and pJNKwas significantly upregulated at the end of preg-
nancy. Although pJNK localization disappeared completely from the nucleus in
the PP1 group, P38 and JNK1 nuclear labeling remained high 24 hours PP.
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Recently, several studies have demonstrated G protein coupled receptor 30
(GPER) can directly bind to estrogen and mediate its action. We investigated
the role and the mechanism of estrogen-induced cardioprotection after ische-
mia-reperfusion using a specific GPER agonist G1. Isolated hearts from male
mice were perfused using Langendorff technique with oxygenated (95% O2
and 5% CO2) Krebs Henseleit buffer (control), with addition of G1 (1mM),
and G1 (1mM)þPD98059 (10mM) to investigate the involvement of Erk path-
way. After 20 min of perfusion, hearts were subjected to 20 min global normo-
thermic (37C) ischemia followed by 40min reperfusion. During the course of
experiment cardiac function was measured and myocardial necrosis was eval-
uated by triphenyltetrazolium chloride (TTC) staining at the end of the reper-
fusion. Mitochondria were isolated after 10 minutes of reperfusion to assess the
calcium load required to induce mPTP opening. G1 treated hearts developed
better functional recovery with higher rate pressure product (RPP,
61405264 vs. 26405334 mmHgxbeats/min, p<0.05). The infarct size de-
creased significantly in G1 treated hearts (2152% vs. 4653% p<0.001) and
the Ca2þ load required to induce mPTP opening increased (2.450.06 vs.
1.650.11 mM/mg mitochondrial protein, p<0.05) as compared to the controls.
The addition of PD 98059 significantly prevents G1 effect on heart function
RPP (4120546 mmHgxbeats/min, p<0.05), infarct size (5352%) and calcium
retention capacity (1.450.11mM/mg mitochondrial protein p<0.05) These
results suggest that GPER activation inhibits the mPTP opening and provide
a cardioprotective effect after ischemia-reperfusion and this effect is mediated
by Erk pathway. Supported by NIH and AHA.
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In mitochondria, the main reactive oxygen species (ROS) generators are com-
plexes I and III. Mitochondrial ROS generation has been implicated in cellular
damage occurring in a variety of pathologies including ischemia/reperfusion
(I/R). Most of the studies have observed an increase of ROS production after
I/R. However, there is evidence of an increase of ROS production after cardi-
oprotection by preconditioning interventions.
We investigated the differential production of ROS by complex I and III in I/R
and sham isolated mitochondria heart mice, and the action of pro-apoptotic
drugs (rotenone and antimycin A) on ROS production by these complexes in
sham animals.
Mitochondrial ROS generation by both complexes was measured using amplex
red in the presence of horseradish-peroxidase. Specific substrates for complex I
(glutmate/malate) and complex II (succinate), and the inhibitors (rotenone and
antimycin-A) were used. Mitochondria from I/R mice produced more ROS
thanmitochondria from shamwhen the substrate for complex I was used. In con-
trast, with the substrate of complex II, mitochondria from I/Rmice produced less
ROS than sham. Application of rotenone and antimycin-A in mitochondria from
sham heart significantly increased ROS production when the substrate for the
complex Iwas used. Surprisingly, these inhibitors decreased theROSproduction
when the substrate for the complex II was used. This data indicate the ambivalent
production of ROS by the respiratory chain complexes I and III, and suggest op-
posite role of ROS depending on the complex being cardio-deleterious for com-
plex I and cardio-protective for complex III. Supported by NIH and AHA.
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